Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
55.61
-0.43 (-0.77%)
At close: Sep 26, 2025, 4:00 PM EDT
55.79
+0.18 (0.32%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Novo Nordisk Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Novo Nordisk stock ranges from a low of $64 to a high of $160. The average analyst price target of $98 forecasts a 76.23% increase in the stock price over the next year.
Price Target: $98.00 (+76.23%)
Analyst Consensus: Buy
* Price targets were last updated on Aug 19, 2025.
Analyst Ratings
The average analyst rating for Novo Nordisk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 6 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Berenberg | Berenberg | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 17, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $105 → $70 | Strong Buy | Maintains | $105 → $70 | +25.88% | Aug 19, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 5, 2025 |
| HSBC | HSBC | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 31, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 30, 2025 |
Financial Forecast
Revenue This Year
318.82B
from 290.40B
Increased by 9.78%
Revenue Next Year
349.70B
from 318.82B
Increased by 9.69%
EPS This Year
24.71
from 22.63
Increased by 9.19%
EPS Next Year
26.86
from 24.71
Increased by 8.69%
Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 338.1B | 417.7B | |||
| Avg | 318.8B | 349.7B | |||
| Low | 303.6B | 311.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.4% | 31.0% | |||
| Avg | 9.8% | 9.7% | |||
| Low | 4.6% | -2.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.65 | 33.34 | |||
| Avg | 24.71 | 26.86 | |||
| Low | 21.83 | 23.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.2% | 34.9% | |||
| Avg | 9.2% | 8.7% | |||
| Low | -3.5% | -4.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.